SOX-2 knockdown has been reported to inhibit the sphere generation ability in glioma cell cultures as well the dedifferentiation and the stemness phenotype thus decreasing tumorigenicity [33–35, 39]. The gene discussed is SOX2; the disease is central nervous system cancer.